Capsule maker and drug formulation specialist Capsugel has been beefing up its production capacities around the globe and will now turn its attention to a plant in Scotland that it picked up in 2013.
The New Jersey-based company said the Edinburgh facility, which it got in 2013 as a piece of its acquisition of Encap Drug Delivery, is already one of the largest manufacturers of liquid- and semi-solid-filled hard capsule pharmaceutical products in the world. But it will more than double its size with a 40,000-square-foot expansion. The expansion will increase its liquid- and semi-solid-fill hard capsule manufacturing capacity for drug products containing high-potency active pharmaceutical ingredients (HPAPIs) and add to the technology platforms the facility offers, like spray drying.
The expansion will be a two-step process starting with new analytical, formulation and quality laboratories focused on formulation needs like bioavailability and HPAPI. The second phase will expand the commercial manufacturing capacity. It didn't disclose how much would be invested in the expansion.
Capsugel last month completed the second phase of a $25 million project in Bend, OR, where it has built a spray-dried dispersion (SDD) facility, adding 20 jobs in the process. Earlier this year, it said it would invest $25 million to build up its vegetarian capsule production at plants in Greenwood, SC; Puebla, Mexico; Colmar, France; and Sagamihara, Japan.
- here's the release